These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 33000253)
1. Long non‑coding RNA PLK1S1 was associated with renal cell carcinoma progression by interacting with microRNA‑653 and altering C‑X‑C chemokine receptor 5 expression. Li W; Yang D; Zhang Y; Zhao S; Li D; Liu M Oncol Rep; 2020 Nov; 44(5):1985-1996. PubMed ID: 33000253 [TBL] [Abstract][Full Text] [Related]
2. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis. Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380 [No Abstract] [Full Text] [Related]
3. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma. Wang Z; Chang X; Zhu G; Gao X; Chang L Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095 [TBL] [Abstract][Full Text] [Related]
4. Long non‑coding RNA MALAT1 correlates with cell viability and mobility by targeting miR‑22‑3p in renal cell carcinoma via the PI3K/Akt pathway. Li Z; Ma Z; Xu X Oncol Rep; 2019 Feb; 41(2):1113-1121. PubMed ID: 30431104 [TBL] [Abstract][Full Text] [Related]
5. miR-33a inhibits cell growth in renal cancer by downregulation of MDM4 expression. Jiang K; Sun F; Zhu J; Luo G; Ban Y; Zhang P Mol Genet Genomic Med; 2019 Aug; 7(8):e833. PubMed ID: 31250570 [TBL] [Abstract][Full Text] [Related]
6. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma. Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-203 Inhibits Long Noncoding RNA HOTAIR and Regulates Tumorigenesis through Epithelial-to-mesenchymal Transition Pathway in Renal Cell Carcinoma. Dasgupta P; Kulkarni P; Majid S; Shahryari V; Hashimoto Y; Bhat NS; Shiina M; Deng G; Saini S; Tabatabai ZL; Yamamura S; Tanaka Y; Dahiya R Mol Cancer Ther; 2018 May; 17(5):1061-1069. PubMed ID: 29440295 [TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HOTTIP promotes renal cell carcinoma progression through the regulation of the miR-615/IGF-2 pathway. Wang Q; Wu G; Zhang Z; Tang Q; Zheng W; Chen X; Chen F; Li Q; Che X Int J Oncol; 2018 Nov; 53(5):2278-2288. PubMed ID: 30226576 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma. Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA Small Nucleolar RNA Host Gene 1 (SNHG1) Promotes Renal Cell Carcinoma Progression and Metastasis by Negatively Regulating miR-137. Zhao S; Wang Y; Luo M; Cui W; Zhou X; Miao L Med Sci Monit; 2018 Jun; 24():3824-3831. PubMed ID: 29874202 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137. Liu JG; Wang HB; Wan G; Yang MZ; Jiang XJ; Yang JY Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5675-5681. PubMed ID: 31298319 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo. Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753 [TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA DUXAP8 Enhances Renal Cell Carcinoma Progression via Downregulating miR-126. Huang T; Wang X; Yang X; Ji J; Wang Q; Yue X; Dong Z Med Sci Monit; 2018 Oct; 24():7340-7347. PubMed ID: 30317248 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA TUG1 promotes cell proliferation and migration of renal cell carcinoma via regulation of YAP. Liu S; Yang Y; Wang W; Pan X J Cell Biochem; 2018 Dec; 119(12):9694-9706. PubMed ID: 30132963 [TBL] [Abstract][Full Text] [Related]
15. A lncRNA TCL6-miR-155 Interaction Regulates the Src-Akt-EMT Network to Mediate Kidney Cancer Progression and Metastasis. Kulkarni P; Dasgupta P; Hashimoto Y; Shiina M; Shahryari V; Tabatabai ZL; Yamamura S; Tanaka Y; Saini S; Dahiya R; Majid S Cancer Res; 2021 Mar; 81(6):1500-1512. PubMed ID: 33500248 [TBL] [Abstract][Full Text] [Related]
16. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway. Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847 [TBL] [Abstract][Full Text] [Related]
17. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis. Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591 [TBL] [Abstract][Full Text] [Related]
18. An increased level of MiR-222-3p is associated with TMP2 suppression, ERK activation and is associated with metastasis and a poor prognosis in renal clear cell carcinoma. Lyu J; Zhu Y; Zhang Q Cancer Biomark; 2020; 28(2):141-149. PubMed ID: 32116235 [TBL] [Abstract][Full Text] [Related]
19. Role of SIRT1/AMPK signaling in the proliferation, migration and invasion of renal cell carcinoma cells. Wang X; Lu Y; Tuo Z; Zhou H; Zhang Y; Cao Z; Peng L; Yu D; Bi L Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907836 [TBL] [Abstract][Full Text] [Related]
20. CRNDE mediates the viability and epithelial-mesenchymal transition of renal cell carcinoma via miR-136-5p. Zhang Y; Lan X; Wang Y; Liu C; Cui T J Recept Signal Transduct Res; 2021 Jun; 41(3):234-244. PubMed ID: 32808846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]